| ECG | Electro-Cardio-Graphy(-Gram); 심전도 = EKG 1. Conducting System Structu... |
|---|---|
| AT III | angiotensin III; antithrombin III |
| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
| ML | I, II, III, IV mucolipidosis I, II, III, IV |
| SI | International System of Units [Fr. le Systeme International d'Unites]; sacroiliac; saline infusion; ... |
| AT | Antithrombin III |
|---|---|
| TAT | Thrombin antithrombin III complex |
| TAT | Thrombin-Antithrombin III |
| AT3 | antithrombin III |
| A III | Angiotensin III |
| 영문 | injection | 한글 | 주입 |
|---|---|---|---|
| 설명 | 액체를 피하조직, 혈관, 또는 장기 등 어떤 부분에 밀어 넣는 것, 또는 그러한 방법으로 투여된 물질을 말한다. |
||
pseudounipolar bipolar III disorder
transverse facial vein
| antithrombin III | <haematology> Antithrombin III is a protein which stimulates the removal of blood clots in the bloodstream. Small blood clots form normally within the bloodstream, but are normally dissolved via the bodys antithrombin III. Conditions that may have an associated low value of antithrombin III include: liver disease and DIC. Normal values are: 0.20 to 0.45 mg/ml or more than 50% of the laboratory control value. Conditions where there is a deficiency of this important protease inhibitor can result in a condition of hypercoagulation, resulting in an increased risk for blood clot formation. Inheritance: autosomal dominant. (13 Jan 1998) |
|---|---|
| congenital antithrombin III deficiency | Antithrombin III is a protein which stimulates the removal of blood clots in the bloodstream. Small blood clots form normally within the bloodstream, but are normally dissolved via the bodys antithrombin III. The deficiency of antithrombin III will result in an increased risk for blood clot formation causing organ damage. This is an inherited as a autosomal dominant trait. Inheritance: autosomal dominant. (27 Sep 1997) |
| antithrombin | Any substance that inhibits or prevents the effects of thrombin in such a manner that blood does not coagulate. A deficiency of antithrombin results in impaired inhibition of coagulation factors IIa, IXa, and Xa in plasma, causing recurrent thrombosis. Antithrombin III, an antithrombin at present somewhat conjectural and biochemically not well characterised. Deficiency is commonly inherited as an autosomal dominant trait; one of the few known mendelizing disorders to which thrombotic disease occurs. Normal antithrombin, an antithrombin naturally occurring in blood and certain tissues under normal conditions in contrast to abnormal states or antithrombin from other sources. (05 Mar 2000) |
| antithrombin test | A procedure for estimating the inhibitory effect of a defibrinated specimen of plasma on the action of thrombin in converting fibrinogen to fibrin. (05 Mar 2000) |
| adrenal cortex injection | An obsolete treatment involving the parenteral administration of extract of the adrenal cortex; formerly used in treatment of Addison's disease. (05 Mar 2000) |
| bolus injection | <procedure> The injection of a drug (or drugs) in a high quantity (called a bolus) at once, the opposite of gradual administration (as in intravenous infusion). (18 Nov 1997) |
| regular insulin injection | A preparation that may contain 20, 40, 80, 100, or 500 USP insulin units per ml, although the trend is toward standardizing all insulin preparations at 100 units per ml; it is administered subcutaneously, occasionally intravenously, and has a rapid onset of action, has a brief duration (5 to 7 hours), and is compatible for mixing with long-acting insulin preparations; used in the treatment of diabetic acidosis and insulin coma. Synonym: regular insulin injection. (05 Mar 2000) |
| Ringer's injection | A sterile solution of sodium chloride, potassium chloride, and calcium chloride, containing in each 100 ml between 820 and 900 mg of sodium chloride, between 25 and 35 mg of potassium chloride, and between 30 and 37 mg of calcium chloride; used intravenously as a fluid and electrolyte replenisher. (05 Mar 2000) |
| water for injection | Water purified by distillation for the preparation of products for parenteral use. (05 Mar 2000) |
| collagen injection | Correction of superficial soft tissue deformities, acne scars, or age-related skin changes by injection (implantation) of collagen; bovine collagen preparations are commonly used. Prior intradermal testing is necessary to exclude hypersensitivity. (05 Mar 2000) |
| selective injection | Injection of contrast medium following selective catheterization of a branch artery or vein for angiography. (05 Mar 2000) |
| sensitizing injection | An injection that sensitises a person so that subsequent exposure to the antigen (allergen) evokes an allergic response. (05 Mar 2000) |
| hypodermic injection | The administration of a remedy in liquid form by injection into the subcutaneous tissues. Synonym: hypodermic. (05 Mar 2000) |
| neutral beam injection | <radiobiology> This is one of the fundamental plasma heating methods. A particle accelerator is used to create fast ion beams (the particle energies are on the order of 100 keV), the ion beam is then passed through a neutral gas region, where the ions neutralise via charge-exchange reactions with the neutral gas. The neutralised beam is then injected into a magnetically confined plasma. The neutral atoms are unaffected (not confined) by the magnetic field, but ionize as they penetrate into the plasma. The high-energy ions then transfer some of their energy to the plasma particles in repeated collisions, and heat the plasma. (09 Oct 1997) |
| subcutaneous injection | The delivery of a medication into the subcutaneous tissues via injection (for example insulin). (27 Sep 1997) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
안티트롬빈III주500단위 - 새창
|
녹십자 |
A10202541 | Antithrombin III, human | 전문의약품 | 삭제 | 분업예외의약품 |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|